In developed countries, Chlamydia trachomatis has become a focus of public health concern because C trachomatis infections occur more frequently than any other sexually transmitted disease (STD). Chlamydial infection rates in the United States and Great Britain appear to have increased over the last decade.'2 Acute salpingitis in females caused by C trachomatis may lead to infertility and/or ectopic pregnancy. C trachomatis can also cause inclusion conjunctivitis and pneumonia of the newborn through perinatal transmission of the infection. Only limited information on the prevalence and trends of chlamydial STDs in developing countries is available.
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women without evidence of exposure to these sexually transmitted diseases, even when controlled for age and the number of lifetime sexual partners.
The seropositivity among never sexually active women indicates the probable presence of Chlamydia pneumoniae infections, while the high seroprevalence of chlamydial antibodies among the sexually active women suggests that sexually transmitted Chlamydia trachomatis infections represent a public health problem not previously quantified in Costa Rica. Further seroepidemiological and/ or culture studies are warranted to determine the incidence and prevalence ofsexually transmitted chlamydial infection among men and younger women.
In developed countries, Chlamydia trachomatis has become a focus of public health concern because C trachomatis infections occur more frequently than any other sexually transmitted disease (STD). Chlamydial infection rates in the United States and Great Britain appear to have increased over the last decade.'2 Acute salpingitis in females caused by C trachomatis may lead to infertility and/or ectopic pregnancy. C trachomatis can also cause inclusion conjunctivitis and pneumonia of the newborn through perinatal transmission of the infection. Only limited information on the prevalence and trends of chlamydial STDs in developing countries is available.
Few population-based or population-representative studies examining the seroprevalence of chlamydial antibodies have been published. Population-based serological studies with detailed demographic information, and data on reproductive health and sexual habits are not available. We report here a study of the seroprevalence of chlamydial antibodies in Costa Rican women 25 to 59 years of age.
Methods

POPULATION
We studied a nationally representative sample of Costa Rican women 25 to 59 years of age who were previously enrolled as controls in a case-control study ofcontraceptive use and the risk ofcervical and breast cancer in Costa Rica. '5 tTwo women with an unknown number of lifetime sexual partners were excluded from the analysis. tTwo women with an unknown number of lifetime sexual partners were excluded from the analysis. $Seven women with an unknown HSV-2 serology result were excluded from the analysis. In a study of female college students 23% of those who reported no prior sexual experience were found to be seropositive.'2 Of interest, the GMT ofnonsexually active seropositive women in our study (34A4) was considerably lower than that of the sexually active seropositive population, which ranged from 67-6 to 155.0 (table 2) . Seropositivity in women reporting no sexual activity may reflect misclassification of the women due to inaccurate information regarding previous 
[61. In addition to the dose-response pattern of increasing antibody prevalence and levels with an increasing number of lifetime sexual partners, we found that HSV-2 and syphilis seropositivity were associated with about a one third increase in chlamydial seropositivity. We would expect women with evidence of one STD to be more likely to show evidence of another STD.
There was no consistent association of chlamydial antibody with a history of PID or infertility. The GMT of seropositive women who reported PID was greater than the GMT of those seropositive women who denied a history of PID; however, there was no increase in chlamydial seropositivity for those women who reported a history ofPID compared with those who did not. The lack of correlation between positive titres and a history of PID may be a result of inaccurate reporting of PID due to misunderstanding of the term, the subclinical nature of much chlamydial PID, or the presence of chlamydial antibodies not acquired from sexually transmitted infections. The reported history of PID in this study population (12-8%) is similar to that reported in the United States.'0
The lack of definitive information on the natural history of chlamydial antibody as well as the crosssectional nature of this study limit speculation regarding the reasons for variation in seroprevalence by age. The differences in seroprevalence and antibody levels by age could represent the influences of: (1) the incidence of infection among cohorts of women, (2) the varying risk of exposure to chlamydial infection with age, (3) the differing rates of infection which result in high antibody titres (such as salpingitis), and/or (4) the changes in antibody levels for individual women over time.
Longitudinal studies could better define the variation of chlamydial antibody with age. Additional cross-sectional studies could provide valuable information for interpretation of results if their designs included men and women less than 25 years of age in the study population, as well as additional information on the sexual habits of the study participants and their partners.
Our results suggest that in Costa Rica, Cpneumoniae infections are probably common and that C trachomatis is an important agent of sexually transmitted infections. In a study oftwo Costa Rican clinic populations, the prevalence of culture-confirmed genital chlamydial infections was low: 2.9% in men visiting an STD clinic and 058% among women visiting a family planning clinic for non-STD reasons.? The relatively low prevalence may be due to the inherent difficulties of chlamydial culture. A recent case-control study in Costa Rica found that C trachomatis was responsible for 33% of hospitalised cases of infant pneumonia. '2 The information provided by this and the other Costa Rican chlamydia studies indicates the need to gather further data to enable future development of a chlamydial control program. Population-based studies of C trachomatis genital infections could provide estimates of current rates of sexually trans- 
